Written and maintained by CASRAI Editorial Board
Last updated
Epocrates is a point-of-care clinical decision support (CDS) and medical reference platform used by physicians, nurse practitioners, physician assistants, pharmacists, and clinical research professionals to verify pharmacotherapy profiles, screen multi-drug regimens for interactions, and consult evidence-based disease guidelines. Founded in 1998 in Silicon Valley as one of the earliest mobile medical reference applications and acquired by athenahealth in 2013, Epocrates operates both as a standalone mobile/web platform and as an embedded pharmacotherapy reference layer inside the athenaOne EHR ecosystem.
What Is Epocrates?
Epocrates curates regulatory labeling (including FDA-approved package inserts and DailyMed updates), primary biomedical literature, and clinical practice guidelines into structured, rapidly searchable point-of-care modules. Its core functional components are summarized in the table below:
| Epocrates Module | Core Clinical & Pharmacological Data Elements |
|---|---|
| Drug Reference Monographs | Structured monographs for brand, generic, and OTC medications covering FDA boxed warnings, adult and pediatric indications, renal and hepatic impairment adjustments, contraindications, adverse reaction profiles, pregnancy and lactation safety narratives, mechanism of action, cytochrome P450 (CYP) metabolism, and payer formulary tiers. |
| MultiCheck Interaction Screener | Simultaneous interaction screening across up to 30 prescription drugs, OTC products, herbs, and dietary supplements, flagging drug–drug, drug–supplement, and therapeutic duplication risks stratified by clinical action level (Contraindicated, Avoid / Use Alternative, Monitor / Modify Tx, and Caution Advised). |
| Pill ID (Pill Identifier) | Visual and physical lookup tool that identifies unmarked or loose solid oral dosage forms using imprint codes, tablet/capsule shape, color, and scoring. |
| Clinical Calculators & Tables | Point-of-care physiological and risk equations—including glomerular filtration rate (eGFR) and Cockcroft–Gault creatinine clearance, body surface area (BSA), anion gap, and clinical severity scores—alongside infectious disease empiric therapy tables. |
| Disease Guides & Lab Reference | Peer-reviewed diagnostic workups, differential diagnosis checklists, and normal reference ranges for serum, hematology, and cerebrospinal fluid laboratory panels. |
How Is Epocrates Used in Clinical Research and Healthcare?
1. Point-of-Care Medication Safety and Polypharmacy Screening
In ambulatory and inpatient clinical practice, adverse drug events frequently stem from unscreened polypharmacy—particularly when patients combine prescription therapies from multiple specialists with over-the-counter analgesics or herbal supplements. Clinicians use the Epocrates MultiCheck engine during medication reconciliation to detect pharmacokinetic interactions (such as strong CYP3A4 or CYP2D6 inhibition/induction and P-glycoprotein transport competition) as well as additive pharmacodynamic toxicities (such as cumulative QTc interval prolongation, serotonin syndrome risk, or central nervous system depression).
2. Concomitant Medication Screening in Clinical Trials
In interventional clinical trials, clinical research coordinators (CRCs) and clinical research associates (CRAs) must verify participant eligibility against strict protocol inclusion/exclusion criteria and maintain complete concomitant medication (CM domain) logs:
- CYP450 and Transporter Exclusion Screening: Early-phase and oncology trial protocols routinely prohibit strong or moderate inhibitors and inducers of specific hepatic enzymes (e.g., CYP3A4, CYP2C9, CYP2C19) within a defined washout window prior to first dose. Investigators use Epocrates pharmacology sections and MultiCheck to screen a participant’s baseline medication list against the protocol’s prohibited-medication appendix.
- Unlabeled Medication Identification at Study Visits: When trial participants bring loose tablets or capsules in weekly pill organizers rather than original pharmacy vials, study coordinators use Epocrates Pill ID (imprint code, color, shape, and scoring) to verify the exact generic active ingredient and strength before mapping the agent to standardized RxNorm or WHODrug Global nomenclature in the electronic case report form (eCRF).
- Renal and Hepatic Function Eligibility Checks: Investigators use built-in creatinine clearance and eGFR calculators alongside hepatic impairment classifications to confirm whether a participant meets organ-function eligibility thresholds at screening.
3. EHR Integration and Academic Citation Standards
Within practices operating athenaOne (athenahealth’s cloud EHR and practice management suite), Epocrates clinical decision support is integrated directly into the e-prescribing and charting workflow, surfacing interaction checks and monograph summaries without context switching. When investigators or academic authors cite point-of-care pharmacotherapy databases in scholarly manuscripts or IRB protocols—similar to referencing Lexicomp or AdisInsight—they should cite the specific drug monograph title, Epocrates publishing platform, and revision/publication year alongside the primary FDA package insert (21 CFR Part 314 labeling).
Sources
- Epocrates, Inc. (an athenahealth company). Epocrates Clinical Decision Support, MultiCheck Drug Interaction Screener, and Monograph Methodology. https://www.epocrates.com/
- athenahealth, Inc. Epocrates Point-of-Care Medical Reference and athenaOne EHR Integration. https://www.athenahealth.com/solutions/epocrates
